Selegiline's neuroprotective capacity revisited

被引：34

作者：

Riederer, P

Lachenmayer, L

机构：

[1] Univ Wurzburg, Clin & Policlin Psychiat & Psychotherapy, D-97080 Wurzburg, Germany

[2] Gen Hosp Barmbek, Dept Clin Neurol, Hamburg, Germany

[3] Gen Hosp Barmbek, NPF Ctr Excellence, Hamburg, Germany

来源：

JOURNAL OF NEURAL TRANSMISSION | 2003年 / 110卷 / 11期

关键词：

D O I：

10.1007/s00702-003-0083-x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1273 / 1278

页数：6

共 29 条

[1]

ALLARDICE JT, 1993, LASER MED SCI, V8, P1

[2] TURNOVER OF BRAIN MONOAMINE-OXIDASE MEASURED INVIVO BY POSITRON EMISSION TOMOGRAPHY USING L-[C-11]DEPRENYL [J].

ARNETT, CD ;

FOWLER, JS ;

MACGREGOR, RR ;

SCHLYER, DJ ;

WOLF, AP ;

LANGSTROM, B ;

HALLDIN, C .

JOURNAL OF NEUROCHEMISTRY, 1987, 49 (02) :522-527

[3] INCREASED LIFE EXPECTANCY RESULTING FROM ADDITION OF L-DEPRENYL TO MADOPAR TREATMENT IN PARKINSONS-DISEASE - A LONGTERM STUDY [J].

BIRKMAYER, W ;

KNOLL, J ;

RIEDERER, P ;

YOUDIM, MBH ;

HARS, V ;

MARTON, J .

JOURNAL OF NEURAL TRANSMISSION, 1985, 64 (02) :113-127

[4] A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition [J].

Clarke, A ;

Johnson, ES ;

Mallard, N ;

Corn, TH ;

Johnston, A ;

Boyce, M ;

Warrington, S ;

MacMahon, DG .

JOURNAL OF NEURAL TRANSMISSION, 2003, 110 (11) :1257-1271

[5] A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition [J].

Clarke, A ;

Brewer, F ;

Johnson, ES ;

Mallard, N ;

Hartig, F ;

Taylor, S ;

Corn, TH .

JOURNAL OF NEURAL TRANSMISSION, 2003, 110 (11) :1241-1255

[6] PARGYLINE AND DEPRENYL PREVENT THE NEUROTOXICITY OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) IN MONKEYS [J].

COHEN, G ;

PASIK, P ;

COHEN, B ;

LEIST, A ;

MYTILINEOU, C ;

YAHR, MD .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 106 (01) :209-210

[7]

FELNER AE, 1979, BIOCHEM PHARMACOL, V28, P995, DOI 10.1016/0006-2952(79)90293-4

[8] SLOW RECOVERY OF HUMAN BRAIN MAO-B AFTER L-DEPRENYL (SELEGELINE) WITHDRAWAL [J].

FOWLER, JS ;

VOLKOW, ND ;

LOGAN, J ;

WANG, GJ ;

MACGREGOR, RR ;

SCHLYER, D ;

WOLF, AP ;

PAPPAS, N ;

ALEXOFF, D ;

SHEA, C ;

DORFLINGER, E ;

KRUCHOWY, L ;

YOO, K ;

FAZZINI, E ;

PATLAK, C .

SYNAPSE, 1994, 18 (02) :86-93

[9] THE MOLECULAR PHARMACOLOGY OF L-DEPRENYL [J].

GERLACH, M ;

RIEDERER, P ;

YOUDIM, MBH .

EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1992, 226 (02) :97-108

[10]

GERLACH M, 2003, PARKINSON KRANKHEIT

← 1 2 3 →